CHARMAIN JOHN: Open Payments
NPI 1598196925 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 46 payments from 17 companies in 2025. Trend: 2023 $1,334 · 2024 $1,450 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $163 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Exact Sciences Corporation | 5 | $105 |
| Amgen Inc. | 5 | $89 |
| ABBVIE INC. | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Lilly USA, LLC | 3 | $46 |
| PFIZER INC. | 2 | $41 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
Products named: AIRSUPRA, Ozempic, Cologuard Collection Kit, OTEZLA, SHINGRIX, MOUNJARO, PREVNAR 20, ACCRUFER.
Industry payments across FL — which companies pay providers there.
